Cardiovascular disease cause of death
Pro Research Analysisby 
Searched over 200M research papers
Consensus Meter
Cardiovascular Disease as a Leading Cause of Death
Global Prevalence of Cardiovascular Disease
Cardiovascular disease (CVD) remains the most common cause of death worldwide. According to the 2013 Global Burden of Disease (GBD) study, CVD was responsible for 17.3 million deaths globally, accounting for 31.5% of all deaths and 45% of all non-communicable disease deaths. This figure is more than twice the number of deaths caused by cancer and exceeds the combined total of all communicable, maternal, neonatal, and nutritional disorders. The burden of CVD has increased over time, with the number of deaths rising from 12.3 million in 1990 to 17.3 million in 2013.
Cardiovascular Disease in Europe
In Europe, CVD continues to be the leading cause of death, causing nearly twice as many deaths as cancer. Despite a significant decrease in mortality from coronary heart disease (CHD) and stroke over the past decade, there are still substantial inequalities between European countries in terms of death rates and the rate of decline in these rates. More than 4 million people die from CVD across Europe each year, with over 1.4 million of these deaths occurring prematurely, before the age of 75. The disparities in treatment rates, particularly surgical interventions, further highlight the inequalities between different European countries.
Cardiovascular Disease in the United States
In the United States, CVD is also the leading cause of death, accounting for 34.4% of the 2.4 million deaths in 2003. The economic impact of CVD is substantial, with healthcare spending and lost productivity exceeding $400 billion in 2006. Factors such as an aging population, the obesity epidemic, underuse of prevention strategies, and suboptimal control of risk factors are expected to exacerbate the future burden of CVD.
Risk Factors and Comorbidities
CVD shares several risk factors with other major diseases, such as cancer. Common risk factors include obesity and diabetes mellitus, suggesting a shared biological basis for these conditions. Chronic inflammation and oxidative stress are significant contributors to the development and progression of CVD. In patients with end-stage renal disease (ESRD) on hemodialysis, CVD is the leading cause of death, with mortality rates 20 times higher than in the general population. Non-traditional risk factors such as chronic volume overload, anemia, and inflammation play a crucial role in this population.
Conclusion
Cardiovascular disease remains the leading cause of death globally, with significant regional disparities in mortality rates and treatment access. The increasing prevalence of CVD, coupled with shared risk factors with other major diseases, underscores the need for comprehensive prevention and treatment strategies. Addressing these challenges requires a multifaceted approach, including improved adherence to clinical guidelines, policy changes, and lifestyle modifications.
Sources and full results
Most relevant research papers on this topic